Ran Lin
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Lifei Qingchang Tang attenuates acute lung injury via the NF-κB and MAPK signaling pathways.
Journal: Journal of Asian natural products research
Published: March 12, 2025
Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome.
Journal: Acta pharmaceutica Sinica. B
Published: January 09, 2025
CT Differentiation and Prognostic Modeling in COVID-19 and Influenza A Pneumonia.
Journal: Academic radiology
Published: December 22, 2024
Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization.
Journal: Bioactive materials
Published: August 01, 2024
Natural pachypodol integrated, lung targeted and inhaled lipid nanomedicine ameliorates acute lung injury via anti-inflammation and repairing lung barrier.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 15, 2024
Eosinophilic gastroenteritis in an elderly men associated with antibiotic use post maxillofacial space infection: a case report.
Journal: Frontiers in medicine
Published: January 15, 2024
Schisandrin A regulates the Nrf2 signaling pathway and inhibits NLRP3 inflammasome activation to interfere with pyroptosis in a mouse model of COPD.
Journal: European journal of medical research
Published: April 30, 2023
Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts.
Journal: The European respiratory journal
Published: August 22, 2021
Synthesis of a novel cyclodextrin-derived chiral stationary phase with multiple urea linkages and enantioseparation toward chiral osmabenzene complex.
Journal: Journal of chromatography. A
Published: November 07, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026